Acute Stroke Imaging Research Roadmap IV: Imaging Selection and Outcomes in Acute Stroke Clinical Trials and Practice.
angiography
clinical trials
ischemic stroke
perfusion imaging
tomography
Journal
Stroke
ISSN: 1524-4628
Titre abrégé: Stroke
Pays: United States
ID NLM: 0235266
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
pubmed:
9
7
2021
medline:
5
1
2022
entrez:
8
7
2021
Statut:
ppublish
Résumé
The Stroke Treatment Academic Industry Roundtable (STAIR) sponsored an imaging session and workshop during the Stroke Treatment Academic Industry Roundtable XI via webinar on October 1 to 2, 2020, to develop consensus recommendations, particularly regarding optimal imaging at primary stroke centers. This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke, industry representatives, and members of the US Food and Drug Administration to discuss imaging priorities in the light of developments in reperfusion therapies, particularly in an extended time window, and reinvigorated interest in brain cytoprotection trials. The imaging session summarized and compared the imaging components of recent acute stroke trials and debated the optimal imaging strategy at primary stroke centers. The imaging workshop developed consensus recommendations for optimizing the acquisition, analysis, and interpretation of computed tomography and magnetic resonance acute stroke imaging, and also recommendations on imaging strategies for primary stroke centers. Recent positive acute stroke clinical trials have extended the treatment window for reperfusion therapies using imaging selection. Achieving rapid and high-quality stroke imaging is therefore critical at both primary and comprehensive stroke centers. Recommendations for enhancing stroke imaging research are provided.
Sections du résumé
BACKGROUND AND PURPOSE
The Stroke Treatment Academic Industry Roundtable (STAIR) sponsored an imaging session and workshop during the Stroke Treatment Academic Industry Roundtable XI via webinar on October 1 to 2, 2020, to develop consensus recommendations, particularly regarding optimal imaging at primary stroke centers.
METHODS
This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke, industry representatives, and members of the US Food and Drug Administration to discuss imaging priorities in the light of developments in reperfusion therapies, particularly in an extended time window, and reinvigorated interest in brain cytoprotection trials.
RESULTS
The imaging session summarized and compared the imaging components of recent acute stroke trials and debated the optimal imaging strategy at primary stroke centers. The imaging workshop developed consensus recommendations for optimizing the acquisition, analysis, and interpretation of computed tomography and magnetic resonance acute stroke imaging, and also recommendations on imaging strategies for primary stroke centers.
CONCLUSIONS
Recent positive acute stroke clinical trials have extended the treatment window for reperfusion therapies using imaging selection. Achieving rapid and high-quality stroke imaging is therefore critical at both primary and comprehensive stroke centers. Recommendations for enhancing stroke imaging research are provided.
Identifiants
pubmed: 34233464
doi: 10.1161/STROKEAHA.121.035132
pmc: PMC8316368
mid: NIHMS1714765
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2723-2733Subventions
Organisme : NINDS NIH HHS
ID : U10 NS086487
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS092076
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS103824
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS117643
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS086872
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS100699
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS100417
Pays : United States
Organisme : NINDS NIH HHS
ID : U01 NS110772
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS075209
Pays : United States
Investigateurs
Opeolu Adeoye
(O)
Saeed Ansari
(S)
Johannes Boltze
(J)
Alastair Buchan
(A)
Napasri Chaisinanunkul
(N)
Christopher Chen
(C)
Thomas P Davis
(TP)
Tatiana Ermakova
(T)
Marc Fisher
(M)
Walid Haddad
(W)
Michael D Hill
(MD)
Gary Houser
(G)
Ashutosh P Jadhav
(AP)
W Taylor Kimberly
(WT)
Jaren W Landen
(JW)
David S Liebeskind
(DS)
Patrick Lyden
(P)
John Lynch
(J)
Chris Mansi
(C)
J Mocco
(J)
Raul G Nogueira
(RG)
Sean I Savitz
(SI)
Lee H Schwamm
(LH)
Kevin N Sheth
(KN)
Yoram Solberg
(Y)
Chitra Venkatasubramanian
(C)
Steven Warach
(S)
Lawrence R Wechsler
(LR)
Bin Zhu
(B)
Nikolaos K Ziogas
(NK)
Références
Lancet. 2020 Mar 14;395(10227):878-887
pubmed: 32087818
Stroke. 2015 Oct;46(10):2981-6
pubmed: 26330447
Ann Neurol. 2000 Apr;47(4):462-9
pubmed: 10762157
Stroke. 2019 Mar;50(3):626-631
pubmed: 30727840
JAMA Neurol. 2017 Jan 1;74(1):34-40
pubmed: 27820620
Stroke. 2019 Jun;50(6):1504-1509
pubmed: 31043151
Stroke. 2013 Sep;44(9):2628-39
pubmed: 23860298
Ann Neurol. 2017 Dec;82(6):995-1003
pubmed: 29205466
Stroke. 2021 Jan;52(1):232-240
pubmed: 33349010
JAMA. 2018 Sep 11;320(10):1017-1026
pubmed: 30208455
J Cereb Blood Flow Metab. 2012 Jan;32(1):50-6
pubmed: 21772309
Int J Stroke. 2019 Jul;14(5):483-490
pubmed: 30947642
Lancet. 2019 Jul 13;394(10193):139-147
pubmed: 31128925
Radiology. 2015 May;275(2):510-20
pubmed: 25633505
Int J Stroke. 2015 Apr;10(3):348-53
pubmed: 23802548
Eur Stroke J. 2021 Mar;6(1):I-LXII
pubmed: 33817340
N Engl J Med. 2019 May 9;380(19):1795-1803
pubmed: 31067369
JAMA Neurol. 2019 Oct 1;76(10):1147-1156
pubmed: 31355873
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Lancet Neurol. 2019 Jan;18(1):46-55
pubmed: 30413385
Stroke. 2018 Mar;49(3):e111-e122
pubmed: 29367333
Clin Radiol. 2009 May;64(5):534-41
pubmed: 19348851
N Engl J Med. 2020 May 21;382(21):1981-1993
pubmed: 32374959
N Engl J Med. 2018 Aug 16;379(7):611-622
pubmed: 29766770
J Neurointerv Surg. 2020 Dec 15;:
pubmed: 33323502
JAMA Neurol. 2019 Jun 1;76(6):641-649
pubmed: 30907934
Stroke. 2018 Oct;49(10):2368-2375
pubmed: 30355095
JAMA. 2016 Sep 27;316(12):1279-88
pubmed: 27673305
Stroke. 2017 Apr;48(4):932-938
pubmed: 28283606
N Engl J Med. 2018 Apr 26;378(17):1573-1582
pubmed: 29694815
Neuroradiology. 2021 Jan;63(1):41-49
pubmed: 32728777
Stroke. 2015 Dec;46(12):3390-7
pubmed: 26514186
JAMA. 2020 Apr 7;323(13):1257-1265
pubmed: 32078683
Stroke. 2017 Feb;48(2):353-360
pubmed: 28008093
Stroke. 2010 Aug;41(8):1659-64
pubmed: 20595670
Stroke. 2006 Apr;37(4):979-85
pubmed: 16514093
Stroke. 2017 Jul;48(7):1862-1868
pubmed: 28583996
Lancet Neurol. 2008 Apr;7(4):299-309
pubmed: 18296121
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
J Cereb Blood Flow Metab. 2016 Oct;36(10):1780-1789
pubmed: 26661203
Int J Stroke. 2015 Jan;10(1):55-60
pubmed: 22974504
Stroke. 2016 Dec;47(12):2966-2971
pubmed: 27895299
Stroke. 2020 Oct;51(10):3147-3155
pubmed: 32933417
Stroke. 2008 May;39(5):1621-8
pubmed: 18403743
Neuroradiology. 2020 Dec;62(12):1617-1626
pubmed: 32621024
J Neuroimaging. 2020 Jul;30(4):471-476
pubmed: 32436311
Stroke. 2020 Mar;51(3):1017-1024
pubmed: 32008460
Front Neurol. 2018 Nov 05;9:933
pubmed: 30455665
Stroke. 2011 Dec;42(12):3435-40
pubmed: 21980202
Stroke. 2016 May;47(5):1389-98
pubmed: 27073243
Lancet. 2019 Jul 20;394(10194):219-229
pubmed: 31133406
Ann Neurol. 2005 Sep;58(3):462-5
pubmed: 16130095
Stroke. 2019 May;50(5):1164-1171
pubmed: 31009354
Stroke. 2019 Dec;50(12):e344-e418
pubmed: 31662037
Eur Stroke J. 2019 Mar;4(1):6-12
pubmed: 31165090
Ann Neurol. 2020 Mar;87(3):419-433
pubmed: 31916270